An Excerpt From JAMA Article August 6, 1997
A licensed vaccine, an aluminum hydroxide-absorbed preparation, is derived from culture fluid supernatant taken from an attenuated strain. The vaccination series consists of 6 subcutaneous doses at 0, 2, and 4 weeks, then at 6, 12, and 18 months, followed by annual boosters. There are insufficient data regarding efficacy against inhalational anthrax in humans, although studies in rhesus monkeys indicate it is protective. If there is information indicating that a BW attack is imminent or may have occurred, prophylaxis of unimmunized individuals with ciprofloxin (500 mg by mouth twice a day), or doxycycline (100 mg by mouth twice a day) is recommended.
To view the Aug 6, 1997 issue of JAMA click here. Note the unusual amount of space in this issue dedicated to BW issues. Are they trying to tell us something?
Gulf War Vets Home Page.